Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/S0140-6736(20)31956-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Medical knowledge and traditional healing practices of the Bororo: reports from an expedition to the interior of Mato Grosso, Brazil, 1911.
Hist Cienc Saude Manguinhos
January 2025
Docente, Universidade Estadual de Goiás. Anápolis - GO - Brasil.
This text analyzes the medical reports of doctor Murillo de Campos on an expedition by the Rondon Commission to the Brazilian state of Mato Grosso in 1911. Originally published as a scientific article, the report begins by detailing the nosological profile in the places visited and the customs of the inhabitants. It then presents a detailed fieldwork report into the healing practices of the Bororo indigenous people in eastern Mato Grosso.
View Article and Find Full Text PDFDamage control resuscitation: how it's done and where we can improve. A view of the Brazilian reality according to trauma professionals.
Rev Col Bras Cir
January 2025
- School of Medical Sciences Orebro university, Department of Surgery - Orebro - OR - Suécia.
Introduction: Hemorrhage is the leading cause of preventable deaths in trauma patients, resulting in 1.5 million deaths annually worldwide. Traditional trauma assessment follows the ABC (airway, breathing, circulation) sequence; evidence suggests the CAB (circulation, airway, breathing) approach to maintain perfusion and prevent hypotension.
View Article and Find Full Text PDFCross-cultural adaptation and evidence of validity of the interprofessional collaboration scale (IPC-BR) for Brazil.
J Interprof Care
January 2025
Graduate Program in Clinical Nursing and Health Care, State University of Ceara, Fortaleza, Brazil.
We aimed to perform cross-cultural adaptation of the Interprofessional Collaboration Scale (IPC-BR) and to evaluate evidence of its validity for the Brazilian hospital context. The research consisted of six steps: translation of the instrument into the new language, synthesis of the translated versions, back-translation, synthesis of the versions in the original language, evaluation of the syntheses by an expert committee, and pilot testing or pretesting and validation of the internal structure of the items of the instrument. The pilot testing involved 4 translators, 14 judges, and 30 healthcare professionals; the validation of the internal structure involved 686 professionals including nurses, physicians and physiotherapists.
View Article and Find Full Text PDFEnhancing rare cancer care in developing countries through patient advocacy: insights from the Desmoid Tumor Brazilian Association.
Ther Adv Med Oncol
January 2025
Department of Medical Oncology, Sarcoma and Bone Tumors Reference Center, A.C. Camargo Cancer Center, R. Prof. Antônio Prudente, 211, São Paulo, SP 01509-010, Brazil.
Introduction: Desmoid tumors are soft-tissue neoplasms that can have profound impacts on the lives of people living with such diseases. As they are rare tumors, patients often have difficulty finding teams specialized in sarcomas and support networks. In low- and middle-income countries, the challenges are exacerbated due to a need for established networks and medication access.
View Article and Find Full Text PDFCemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial.
Eur J Cancer
January 2025
Department of Gynecology and Obstetrics, University of California, Irvine, CA, USA.
Aim: Cemiplimab has demonstrated significantly longer survival than physician's choice of chemotherapy in patients with recurrent cervical cancer after first-line platinum-containing chemotherapy. We report the final survival analysis from the phase III randomized study (EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9).
Methods: Cemiplimab (n = 304) or chemotherapy (n = 304) were administered every 3 weeks.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!